Indianapolis, IN, United States of America

William H W Lunn

This inventor holds 2 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2002-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William H W Lunn. Retrieved from https://idiyas.com/inventor/william-h-w-lunn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 1


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of William H W Lunn

Introduction

William H W Lunn is a notable inventor based in Indianapolis, IN. He has made significant contributions to the field of medical science, particularly in the area of neuropeptide research. With a total of 2 patents to his name, Lunn's work has the potential to impact the treatment of various physiological conditions.

Latest Patents

Lunn's latest patents include innovative methods aimed at addressing critical health issues. One patent focuses on "Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y." This research is crucial as neuropeptide Y is linked to several disorders. His second patent, "Methods of inhibiting the effects of amyloidogenic proteins," targets another significant area of medical research, particularly in relation to neurodegenerative diseases.

Career Highlights

Lunn is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. His role at Eli Lilly allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Lunn has worked alongside esteemed colleagues such as Robert F Bruns, Jr and J Jeffry Howbert. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

William H W Lunn's contributions to medical science through his patents and collaborations highlight his dedication to innovation. His work continues to pave the way for advancements in healthcare and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…